Lataa...
C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
BACKGROUND: Pulmonary fibrosis has high rates of mortality and morbidity; however, no effective pharmacological therapy has been established. C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, selectively binds to the transmembrane guanylyl cyclase (GC)-B receptor and exer...
Tallennettuna:
| Julkaisussa: | Respir Res |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761143/ https://ncbi.nlm.nih.gov/pubmed/26895702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0335-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|